Cargando…
Use of nonconventional biomarkers in acute coronary syndrome in COVID-19 pandemic
Autores principales: | Makkar, Kunaal, Sharma, Yash Paul, Malhi, Tejinder Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier, a division of RELX India, Pvt. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629331/ http://dx.doi.org/10.1016/j.ihj.2021.11.124 |
Ejemplares similares
-
Observational study in a tertiary care center in North India comparing demographic profile and outcome in patients with COVID-19 ACS and non COVID-19 ACS
por: Makkar, Kunaal, et al.
Publicado: (2021) -
Role of fibrinogen, albumin and fibrinogen to albumin ratio in determining angiographic severity and outcomes in acute coronary syndrome
por: Makkar, Kunaal, et al.
Publicado: (2023) -
Cardiogenic shock complicating acute myocardial infarction in COVID pandemic – Clinical characteristics, management and outcomes
por: Sharma, Yash Paul, et al.
Publicado: (2021) -
Angiographic profile and outcomes in persistent non-valvular atrial fibrillation: A study from tertiary care center in North India
por: Sharma, Yash Paul, et al.
Publicado: (2022) -
Nonconventional Markers of Sepsis
por: Kustán, Péter, et al.
Publicado: (2017)